Utility Of Citogenex Administration In Patients With Colon-Rectal Cancer (CITOGENEX PA)
Sponsor: University of Palermo
Suspended
the study has never started
This NA trial investigates Colonic Neoplasms and is currently suspended. University of Palermo leads this study, which shows 6 recorded versions since 2026 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Suspended NA
-
Jul 2024 — Sep 2024 [monthly]
Suspended NA
-
Jan 2021 — Jul 2024 [monthly]
Suspended NA
-
Jun 2018 — Jan 2021 [monthly]
Suspended NA
-
Dec 2017 — Jun 2018 [monthly]
Suspended NA
▶ Show 1 earlier version
-
Jan 2017 — Dec 2017 [monthly]
Suspended NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Palermo
For direct contact, visit the study record on ClinicalTrials.gov .